Amit G.

Founder CEO at OmicsX

Role: Founder, CEO at Omicsx
Location: New Delhi, IN
LinkedIn followers: 500 followers

General Business & ManagementView LinkedIn profile

About Amit G.

Vast entrepreneurial experience of 15+ years, in establishing and successfully running…

Experience

Founder, CEO
Omicsx
Feb 2011 — Present · Agra, IN
OmicsX is a knowledge intensive group, working extensively in mapping global innovations in field of Drug Development, Drug Discovery, Drug Delivery, Drug Diagnostics and Device.In past years Group has developed some of the world\'s largest proprietary technology mapping platform and is only group, which provides ranking to Oncology and Neurology Drug Discovery BioStartups.

Skills

Molecular Biology
Clinical Development
Managing Start-Ups
Entrepreneurship
Cell
Oncology
Drug Discovery
Clinical Trials
Start-Ups
Commercialization
Laboratory
Biotechnology
Drug Development
Bioinformatics
Biopharmaceuticals
Lifesciences
Cancer
Pharmaceutical Industry
Cell Culture
Genomics

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@omicsx.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Omicsx

Biotechnology Research · 18 employees · Founded 2011 · Agra, Uttar Pradesh, India

OmicsX builds decision operating systems that turn evidence into governed permission for biotech teams. We create structured decision products for DAC, ADC, target selection, vendor evaluation, CMC truth verification, clinical advancement, and portfolio risk governance, so teams know what is ready to advance, what must stay constrained, and what should stop. Instead of just delivering reports, we design the operating logic that governs high-consequence biotech choices across: DAC Decision OS – Target logic, CMC, dose/BAD optimization, clinical governance, risk-to-capital progression ADC Decision Systems – Payload, linker, translational proof, development gating Target Decision OS – Modality fit, development readiness, investment quality Vendor Selection OS – CDMO, CRO, assay, diagnostics partner evaluation CMC Truth Systems – Functional sameness, drift detection, regulator-defensible handoffs Portfolio & Capital Decision Logic – Prioritization, risk containment, funding gates Our systems convert evidence into explicit permission, constraints, and downstream consequences, ensuring CMC, clinical, regulatory, capital, and BD teams all operate from identical truth states. Built for biotech founders & CEOs, CSOs & platform leaders, CMC/development operators, clinical/translational heads, and specialist investors who need operator-grade clarity for expensive advancement decisions. Built on 15+ years of proprietary biotech intelligence across oncology, neurology, ADCs, TPDs/DACs, and emerging modalities, now structured as governed decision architecture rather than static reports. Our decision systems inherit insights from drug developers and 2,500+ CROs, delivering pattern recognition at operating system scale. Most biotech programs don\'t fail from lack of data. They fail when confidence moves faster than proof. Signal becomes permission. Handoffs lose constraints. Capital funds interpretation drift. OmicsX systems prevent that failure mode.

omicsx.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Amit G.

Experience

Founder, CEO

Skills

Find verified contacts for anyone on LinkedIn